Normal allele: GG
Associated with asthma exacerbations regardless of treatment regimen. 1.3-fold increased risk that inhaler use in children may exacerbate asthma.
Polymorphism rs1042713 is related to topics like this:
Research and publications:
15500681 Detecting imbalanced expression of SNP alleles by minisequencing on microarrays.
15726497 Gene-environment interaction effects on the development of immune responses in the 1st year of life
15867853 Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes.
16322642 beta-Adrenergic receptor polymorphisms and response to salmeterol.
16385446 A testing framework for identifying susceptibility genes in the presence of epistasis
17143563 beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.
17199132 beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort.
17512307 Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations.
18615004 beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.
18647184 Association between polymorphisms in the beta2-adrenoceptor gene and migraine in women.
19111454 Genetic association analysis of COPD candidate genes with bronchodilator responsiveness.
19553224 Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance.
19559392 A candidate gene association study of 77 polymorphisms in migraine
19565482 Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains.
19576569 Diverse evolutionary histories for beta-adrenoreceptor genes in humans.
19717003 Pediatric obesity: etiology and treatment
19745160 Trend tests for genetic association using population-based cross-sectional complex survey data.
20049212 Traffic-related air pollution, oxidative stress genes, and asthma (ECHRS).
20078877 Gene polymorphisms in association with emerging cardiovascular risk markers in adult women
20401335 Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.
20435227 Clinical assessment incorporating a personal genome.
20521218 Progress toward genetic tailoring of heart failure therapy.
20592916 Pharmacogenomic approaches to asthma treatment.
20816195 Analyses of shared genetic factors between asthma and obesity in children.
21233812 ADRB2 and LEPR gene polymorphisms: synergistic effects on the risk of obesity in Japanese.
21437030 Genetics and cardiovascular system: influence of human genetic variants on vascular function.
21515823 Genetic predictors for stroke in children with sickle cell anemia.
21573014 Genes involved in vasoconstriction and vasodilation system affect salt-sensitive hypertension.
21894447 Are centenarians genetically predisposed to lower disease risk?
21981957 Pediatric obesity: etiology and treatment.
22058430 Genetic basis of pain variability: recent advances.
22383665 ADRB2 polymorphisms and budesonide/formoterol responses in COPD.
22552919 Bioinformatics and variability in drug response: a protein structural perspective.
22769019 Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population.
22900502 Association between β2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS.
22992668 Pharmacogenomics knowledge for personalized medicine.
23126384 Tailored second-line therapy in asthmatic children with the Arg(16) genotype.
23229623 ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936.
23300409 Chapter 7: Pharmacogenomics.